SELLAS Life Sciences Group, Inc. (SLS) vs Vericel Corporation (VCEL)
A side-by-side comparison of SELLAS Life Sciences Group, Inc. and Vericel Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SLS
SELLAS Life Sciences Group, Inc.
$11.43HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
VCEL
Vericel Corporation
$40.18HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — SLS vs VCEL
growth of $100 · dividends reinvested · last 10ySLS -99.9% (-48.7%/yr)VCEL +1341.1% (+30.6%/yr)VCEL compounded faster over this window
Log scale — wide-divergence pair
SLS VCEL
SLS vs VCEL: by the numbers
- •SLS is the larger company ($2.13B vs $2.06B market cap).
- •VCEL is profitable (7.91% net margin) while SLS runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | SLS | VCEL |
|---|---|---|
| P/E ratio | N/A | 85.89 |
| Forward P/E | N/A | 75.18 |
| PEG ratio | N/A | 2.18 |
| P/S ratio | N/A | 6.72 |
| P/B ratio | 15.44 | 5.56 |
| EV / EBITDA | N/A | 65.36 |
| FCF yield | N/A | 2.41% |
Profitability
| Metric | SLS | VCEL |
|---|---|---|
| Gross margin | 0.00% | 74.56% |
| Operating margin | 0.00% | 5.95% |
| Net margin | 0.00% | 7.91% |
| ROE | -23.58% | 6.55% |
| ROIC | -25.45% | 3.79% |
Growth (annualized)
| Metric | SLS | VCEL |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 15.11% |
| EPS CAGR (5Y) | N/A | 39.14% |
| FCF CAGR (5Y) | N/A | 14.83% |
| Total return CAGR (5Y) | 6.20% | -4.18% |
Frequently asked
- Is SLS or VCEL more profitable?
- VCEL runs the higher net margin — SLS at 0.00% versus VCEL at 7.91%.
- How have SLS and VCEL total returns compared?
- Over the past 10 years, SLS delivered -49.07% and VCEL delivered 30.18% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Vericel P/E ratioSELLAS Life Sciences ROEVericel ROESELLAS Life Sciences operating marginVericel operating marginSELLAS Life Sciences revenue growthVericel revenue growthSELLAS Life Sciences free cash flowVericel free cash flow
SELLAS Life Sciences & Vericel appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.